Grey Matters Health Raises CAD $1.12M in Mixed Equity-Debt Financing…

Event summary

Grey Matters Health closed a CAD $1.12M private placement, split between equity and convertible debentures.
Second tranche raised $520K: $270K from 675K equity units at $0.40 each, $250K from convertible debentures.
Proceeds earmarked for U.S. Alzheimer’s neuroimaging clinic expansion and working capital.
Securities subject to 4-month hold period under Canadian securities laws.

The big picture

Grey Matters' mixed equity-debt financing reflects the capital-intensive nature of specialized neuroimaging clinic development. The $1.12M raise positions the company to advance its Alzheimer’s detection program amid growing demand for early-stage neurodegenerative disease diagnostics. The structure suggests confidence in near-term revenue generation to service the 10% convertible debt.

What we're watching

Execution Risk: Whether Grey Matters can deliver its U.S. clinic expansion on schedule with the raised capital.
Debt Conversion: The pace at which convertible debentures may convert to equity at $0.455 per share.
Market Dynamics: How Alzheimer’s early detection market competition impacts Grey Matters' clinic rollout strategy.